Anam Fatma

Anam Fatma is a seasoned professional with over 6 years of successful experience in pharmaceutical sales and marketing.

Anam has a diverse skill set including expertise in Sales, Communication, Data Visualization, Management, and Sales Presentations.

Anam made notable contributions in the setup of respiratory and prostate cancer therapy businesses for AstraZeneca and Ferring Pharmaceuticals in Delhi and Mumbai.

Currently, Anam is spearheading the launch of a revolutionary brand in the Lung cancer division which offers targeted therapy for BRAF mutated patients in mNSCLC and mMelanoma in the Indian market, in addition to managing another product approved for ALK+ mutation in Lung cancer.

Anam holds an MBA in Marketing/Marketing Management from Welingkar Institute of Management and a Masters in Clinical Research from Jamia Hamdard.

With a background at Novartis Oncology, Ferring Pharmaceuticals, and AstraZeneca, Anam brings a wealth of experience and expertise in the pharmaceutical industry.